1tl9
From Proteopedia
Line 4: | Line 4: | ||
|PDB= 1tl9 |SIZE=350|CAPTION= <scene name='initialview01'>1tl9</scene>, resolution 1.80Å | |PDB= 1tl9 |SIZE=350|CAPTION= <scene name='initialview01'>1tl9</scene>, resolution 1.80Å | ||
|SITE= | |SITE= | ||
- | |LIGAND= <scene name='pdbligand= | + | |LIGAND= <scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene> |
- | |ACTIVITY= [http://en.wikipedia.org/wiki/Calpain-1 Calpain-1], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.22.52 3.4.22.52] | + | |ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/Calpain-1 Calpain-1], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.22.52 3.4.22.52] </span> |
|GENE= CAPN1, CLS1 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=10116 Rattus norvegicus]) | |GENE= CAPN1, CLS1 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=10116 Rattus norvegicus]) | ||
+ | |DOMAIN= | ||
+ | |RELATEDENTRY=[[1kxr|1KXR]], [[1mdw|1MDW]], [[1dfo|1DFO]], [[1kfu|1KFU]], [[1kfx|1KFX]], [[1nx0|1NX0]], [[1tlo|1TLO]] | ||
+ | |RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1tl9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1tl9 OCA], [http://www.ebi.ac.uk/pdbsum/1tl9 PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1tl9 RCSB]</span> | ||
}} | }} | ||
Line 27: | Line 30: | ||
[[Category: Davies, P L.]] | [[Category: Davies, P L.]] | ||
[[Category: Moldoveanu, T.]] | [[Category: Moldoveanu, T.]] | ||
- | [[Category: ACE]] | ||
- | [[Category: CA]] | ||
[[Category: covalently-linked inhibitor at the active site cysteine forms a hemithioacetal]] | [[Category: covalently-linked inhibitor at the active site cysteine forms a hemithioacetal]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 30 23:57:45 2008'' |
Revision as of 20:57, 30 March 2008
| |||||||
, resolution 1.80Å | |||||||
---|---|---|---|---|---|---|---|
Ligands: | , | ||||||
Gene: | CAPN1, CLS1 (Rattus norvegicus) | ||||||
Activity: | Calpain-1, with EC number 3.4.22.52 | ||||||
Related: | 1KXR, 1MDW, 1DFO, 1KFU, 1KFX, 1NX0, 1TLO
| ||||||
Resources: | FirstGlance, OCA, PDBsum, RCSB | ||||||
Coordinates: | save as pdb, mmCIF, xml |
High resolution crystal structure of calpain I protease core in complex with leupeptin
Overview
The endogenous calpain inhibitor, calpastatin, modulates some patho-physiological aspects of calpain signaling. Excess calpain can escape this inhibition and as well, many calpain isoforms and autolytically generated protease core fragments are not inhibited by calpastatin. There is a need, therefore, to develop specific, cell-permeable calpain inhibitors to block uncontrolled proteolysis and prevent tissue damage during brain and heart ischemia, spinal-cord injury and Alzheimer's diseases. Here, we report the first high-resolution crystal structures of rat mu-calpain protease core complexed with two traditional, low molecular mass inhibitors, leupeptin and E64. These structures show that access to a slightly deeper, but otherwise papain-like active site is gated by two flexible loops. These loops are divergent among the calpain isoforms giving a potential structural basis for substrate/inhibitor selectivity over other papain-like cysteine proteases and between members of the calpain family.
About this Structure
1TL9 is a Single protein structure of sequence from Rattus norvegicus. Full crystallographic information is available from OCA.
Reference
Crystal structures of calpain-E64 and -leupeptin inhibitor complexes reveal mobile loops gating the active site., Moldoveanu T, Campbell RL, Cuerrier D, Davies PL, J Mol Biol. 2004 Nov 5;343(5):1313-26. PMID:15491615
Page seeded by OCA on Sun Mar 30 23:57:45 2008